EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma

Alex José de Melo Silva iD, Juliana Ellen de Melo Gama iD, Sheilla Andrade de Oliveira iD

International Journal of Cell Biology · 2024-01 · 2024 (1)

DOI: 10.1155/2024/4972523 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cell Biology, online erschienen am 19.08.2024. Verfasst von Alex José de Melo Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology Aggeu Magalhães Institute, Recife, Pernambuco, Brazil. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer has been reported to be one of the most malignant diseases in the world. It is late diagnosis consequently leads to a difficult treatment, as the cancer reached an advanced stage. Hepatocellular carcinoma (HCC) is the primary type of cancer diagnosed in the liver, with deadly characteristics and a poor prognosis. The first‐in‐line treatment for advanced HCC is sorafenib. Sorafenib acts by inhibiting cell proliferation and by inducing apoptosis as well as blocks receptors associated with these mechanisms. Due to its constant use, sorafenib resistance has been described, especially to proteins of the Bcl‐2 family, and their overexpression of Bcl‐XL and Mcl‐1. This review focuses on the role of the Bcl‐2 proteins in relation to sorafenib resistance as a consequence of first‐in‐line treatment in HCC.

Schlagwörter

Stichwörter der Autor:innen

Bcl-2 familyhepatocellular carcinomaresistancesorafenib

Autor:innen und Institutionen

  • Department of Immunology Aggeu Magalhães Institute, Recife, Pernambuco, Brazil.

ORCID-Profile: Alex José de Melo Silva, Juliana Ellen de Melo Gama, Sheilla Andrade de Oliveira

Zitieren

APA

de Melo Silva, A. J., de Melo Gama, J. E., & de Oliveira, S. A. (2024). The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma. International Journal of Cell Biology, 2024(1). https://doi.org/10.1155/2024/4972523

Vancouver

de Melo Silva AJ, de Melo Gama JE, de Oliveira SA. The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma. International Journal of Cell Biology. 2024;2024(1). doi:10.1155/2024/4972523

BibTeX
@article{deMeloSilva2024,
  author = {de Melo Silva, Alex José and de Melo Gama, Juliana Ellen and de Oliveira, Sheilla Andrade},
  title = {The Role of Bcl‐2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma},
  journal = {International Journal of Cell Biology},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/4972523}
}
Kostenlos starten →